Literature DB >> 25124036

Human trefoil factor 2 is a lectin that binds α-GlcNAc-capped mucin glycans with antibiotic activity against Helicobacter pylori.

Franz-Georg Hanisch1, David Bonar2, Nils Schloerer3, Horst Schroten4.   

Abstract

Helicobacter pylori infection is the major cause of gastric cancer and remains an important health care challenge. The trefoil factor peptides are a family of small highly conserved proteins that are claimed to play essential roles in cytoprotection and epithelial repair within the gastrointestinal tract. H. pylori colocalizes with MUC5AC at the gastric surface epithelium, but not with MUC6 secreted in concert with TFF2 by deep gastric glands. Both components of the gastric gland secretome associate non-covalently and show increased expression upon H. pylori infection. Although blood group active O-glycans of the Lewis-type form the basis of H. pylori adhesion to the surface mucin layer and to epithelial cells, α1,4-GlcNAc-capped O-glycans on gastric mucins were proposed to inhibit H. pylori growth as a natural antibiotic. We show here that the gastric glycoform of TFF2 is a calcium-independent lectin, which binds with high specificity to O-linked α1,4-GlcNAc-capped hexasaccharides on human and porcine stomach mucin. The structural assignments of two hexasaccharide isomers and the binding active glycotope were based on mass spectrometry, linkage analysis, (1)H nuclear magnetic resonance spectroscopy, glycan inhibition, and lectin competition of TFF2-mucin binding. Neoglycolipids derived from the C3/C6-linked branches of the two isomers revealed highly specific TFF2 binding to the 6-linked trisaccharide in GlcNAcα1-4Galβ1-4GlcNAcβ1-6(Fucα1-2Galβ1-3)GalNAc-ol(Structure 1). Supposedly, lectin TFF2 is involved in protection of gastric epithelia via a functional relationship to defense against H. pylori launched by antibiotic α1,4-GlcNAc-capped mucin glycans. Lectin-carbohydrate interaction may have also an impact on more general functional aspects of TFF members by mediating their binding to cell signaling receptors.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Glycomics; Glycosylation; Helicobacter pylori; Lectin; Mucin; Mucin-type O-Glycans; Trefoil Factor Family 2 (TFF2)

Mesh:

Substances:

Year:  2014        PMID: 25124036      PMCID: PMC4183777          DOI: 10.1074/jbc.M114.597757

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  O-linked N,N'-diacetyllactosamine (LacdiNAc)-modified glycans in extracellular matrix glycoproteins are specifically phosphorylated at subterminal N-acetylglucosamine.

Authors:  Isabelle Breloy; Sandra Pacharra; Philipp Ottis; David Bonar; Ammi Grahn; Franz-Georg Hanisch
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

2.  The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach.

Authors:  F E May; J I Semple; J L Newton; B R Westley
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Microscale sequencing of O-linked oligosaccharides using mild periodate oxidation of alditols, coupling to phospholipid and TLC-MS analysis of the resulting neoglycolipids.

Authors:  M S Stoll; E F Hounsell; A M Lawson; W G Chai; F Z Ten
Journal:  Eur J Biochem       Date:  1990-05-20

4.  Trefoil factor 2 in gland mucous cell mucin in the mucous gel covering normal or damaged gastric mucosa using the Mongolian gerbil model.

Authors:  Kazufumi Suzuki; Masayoshi Hayama; Michitaka Nakamura; Kazuyoshi Yamauchi; Fukuto Maruta; Shinichi Miyagawa; Hiroyoshi Ota
Journal:  Scand J Gastroenterol       Date:  2006-12       Impact factor: 2.423

5.  Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori.

Authors:  Yannick Rossez; Emmanuel Maes; Tony Lefebvre Darroman; Pierre Gosset; Chantal Ecobichon; Marie Joncquel Chevalier Curt; Ivo G Boneca; Jean-Claude Michalski; Catherine Robbe-Masselot
Journal:  Glycobiology       Date:  2012-04-21       Impact factor: 4.313

6.  H pylori colocalises with MUC5AC in the human stomach.

Authors:  G R Van den Brink; K M Tytgat; R W Van der Hulst; C M Van der Loos; A W Einerhand; H A Büller; J Dekker
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

7.  Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice.

Authors:  James G Fox; Arlin B Rogers; Mark T Whary; Zhongming Ge; Masa Ohtani; Evelyn Kurt Jones; Timothy C Wang
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

8.  Structural studies on fetal mucins from human amniotic fluid. Core typing of short-chain O-linked glycans.

Authors:  F G Hanisch; J Peter-Katalinic
Journal:  Eur J Biochem       Date:  1992-04-15

9.  Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation.

Authors:  H H-X Xia; Y Yang; S K Lam; W M Wong; S Y Leung; S T Yuen; G Elia; N A Wright; B C-Y Wong
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

10.  The gastric mucus layers: constituents and regulation of accumulation.

Authors:  Mia Phillipson; Malin E V Johansson; Johanna Henriksnäs; Joel Petersson; Sandra J Gendler; Stellan Sandler; A Erik G Persson; Gunnar C Hansson; Lena Holm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

View more
  28 in total

Review 1.  Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.

Authors:  William J Janssen; Adrianne L Stefanski; Bruce S Bochner; Christopher M Evans
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

Review 2.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

3.  Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.

Authors:  Shiho Asaka; Tomoyuki Nakajima; Masanobu Momose; Tsutomu Miyamoto; Takeshi Uehara; Hiroyoshi Ota
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

Review 4.  Trefoil Factor Peptides and Gastrointestinal Function.

Authors:  Eitaro Aihara; Kristen A Engevik; Marshall H Montrose
Journal:  Annu Rev Physiol       Date:  2016-12-15       Impact factor: 19.318

Review 5.  Why do we study animal toxins?

Authors:  Yun Zhang
Journal:  Dongwuxue Yanjiu       Date:  2015-07-18

6.  Merging carbohydrate chemistry with lectin histochemistry to study inhibition of lectin binding by glycoclusters in the natural tissue context.

Authors:  Sabine André; Herbert Kaltner; Klaus Kayser; Paul V Murphy; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2015-11-09       Impact factor: 4.304

7.  Loss of Trefoil Factor 2 Sensitizes Rat Pups to Systemic Infection with the Neonatal Pathogen Escherichia coli K1.

Authors:  Alex J McCarthy; George M H Birchenough; Peter W Taylor
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

Review 8.  Trefoil Factor Family: Unresolved Questions and Clinical Perspectives.

Authors:  Nayara Braga Emidio; Werner Hoffmann; Stuart M Brierley; Markus Muttenthaler
Journal:  Trends Biochem Sci       Date:  2019-02-18       Impact factor: 13.807

Review 9.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

10.  TFF Peptides Play a Role in the Immune Response Following Oral Infection of Mice with Toxoplasma Gondii.

Authors:  Ting Fu; Eva B Znalesniak; Thomas Kalinski; Luisa Möhle; Aindrila Biswas; Franz Salm; Ildiko Rita Dunay; Werner Hoffmann
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.